Megakaryocytic protein tyrosine kinase I
US6908984B2 · kind B2 · utility
0Cited by
2References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 16, 2001 |
| Grant date | Jun 21, 2005 |
| Priority date | — |
| Expiry date | Dec 29, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel cytoplasmic tyrosine kinases isolated from megakaryocytes (megakaryocyte kinases or MKKs) which are involved in cellular signal transduction pathways and to the use of these novel proteins in the diagnosis and treatment of disease. The present invention further relates to specific megakaryocyte kinases, designated MKK1, MKK2, and MKK3, and their use as diagnostic and therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.